Kinaset Therapeutics, Inc.

Kinaset Therapeutics, Inc. is on a mission to create a convenient, inhaled treatment for severe asthma for use across the spectrum of disease phenotypes, including the insufficiently addressed non-eo

The confluence of data science and molecular biology fuels expectations among biopharma industry leaders for another year of breakthrough innovation in human therapeutics. More than 70 executives and

With understanding of immune function advancing in leaps and bounds and a continuing proliferation of tools to manipulate it, expectations are high for advances in oncology and immunology over the com

Vectura Group plc , a stalwart of the UK biotech sector, has agreed to be acquired by The Carlyle Group in a deal worth £958m ($1.36bn), the latest example of private equity firm's increased interest